Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test

Clinical trial NCT03810144 · COMPLETED

Trial details

NCT number: NCT03810144
Sponsor: Sequenom, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Rheumatoid Arthritis

Start date: 2018-10-22
Primary completion: 2022-08-16
Enrollment: 444

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.